Skip to content

Construction and Application of Medication Safety Intervention Program for Elderly Patients with Chronic Diseases on COM-B Model

A study on the safe management strategy of long prescription medication for patients with chronic diseases based on patient empowerment

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300072716
Enrollment
Unknown
Registered
2023-06-21
Start date
2024-11-01
Completion date
Unknown
Last updated
2025-10-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Older adults with diabetes and comorbidities

Interventions

Intervention group:Patients receive medication safety education via the WeChat platform.
Control group:Patients receive routine care at the community health service center and medication safety education using printed materials.

Sponsors

School of General Practice and Continuing Education, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Aged 60–80 years; 2. Diagnosed with type 2 diabetes mellitus and at least one other chronic condition; 3. Currently using at least one antidiabetic medication; 4. Clear consciousness, with normal comprehension and communication abilities; 5. Able to use a smartphone; 6. Permanent resident of Beijing.

Exclusion criteria

Exclusion criteria: 1. Presence of suspected acute diabetic complications at enrollment, such as recurrent hypoglycemia, diabetic ketoacidosis, or hyperosmolar hyperglycemic state; 2. Concomitant severe diseases, including malignancy, advanced cardiac/hepatic/renal dysfunction, or acute cerebrovascular disease; 3. Patients with visual or hearing impairment, or with restricted physical mobility; 4. Patients with significant cognitive impairment or psychiatric disorders; 5. Planned residence outside Beijing during the 3-month study period, preventing completion of the study tasks; 6. Participation in other clinical trials.

Design outcomes

Primary

MeasureTime frame
Patient Participation in Medication Safety;

Secondary

MeasureTime frame
Medication Adherence;Perceived Efficacy in Patient–Physician Interactions;medication knowledge;Fasting blood glucose;

Countries

China

Contacts

Public ContactDu Juan

School of General Practice and Continuing Education, Capital Medical University

cuckoo@ccmu.edu.cn+86 135 2015 9340

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026